CUPISCO & GEFCAPI04: molecularly-guided therapy in cancer of unknown primary
Kai-Keen Shiu, FRCP, PhD, University College London Hospitals NHS Foundation Trust, London, UK, gives us an update on the CUPISCO…
Related Articles
Key takeaways from ASCO 2024: advances in kidney cancer biomarkers and neoadjuvant therapy
Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, discusses key takeaways from the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago,…
Future directions of targeted agents in the treatment of thyroid and neuroendocrine tumors
Enrique Grande, MD, PhD, MD Anderson Cancer Centre Madrid, Madrid, Spain, discusses the therapies available for differentiated thyroid and endocrine tumors, and the trials currently…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
KEYNOTE-522: final OS findings of pembrolizumab and chemotherapy in TNBC
Peter Schmid, FRCP, MD, PhD, Barts Cancer Institute, London, UK, discusses the final overall survival (OS) results from the Phase III KEYNOTE-522 trial (NCT03036488) of…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
MARIPOSA: mechanisms of resistance to 1L amivantamab + lazertinib in pts with EGFR-m NSCLC
Benjamin Besse, MD, PhD, Gustave Roussy, Villejuif, France, discusses updated findings from the Phase III MARIPOSA study (NCT04487080), where first-line (1L) treatment with amivantamab plus…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…